Merck Price Prediction: Sac-TMT Could Lift MRK to Peak
Analysts are arguing that Merck's sac-TMT program could unlock substantial upside for MRK, supported by a strong pipe...
Safest stablecoins in 2026 balance resilience, reserve quality, and regulatory alignment. This primer outlines evaluation criteria.
15,169 articlesAnalysts are arguing that Merck's sac-TMT program could unlock substantial upside for MRK, supported by a strong pipe...
As markets bounce between frenzy and caution, investors are weighing two paths: a focused bet on seven mega-cap names...
Dallas-Fort Worth remains projected as the top housing market for a second year, signaling strong demand and rising h...
Poland has reached a trillion-dollar economy milestone in 2025, lifting tens of millions into a higher standard of li...
A January 12, 2026 bill aims to ban lawmakers and families from buying stocks, with public notice and hefty penalties...
Lumentum shares jumped about 12% on a $2 billion NVIDIA partnership, as AI data-center buildout and robust backlog un...
Meta Platforms paused the public rollout of its Avocado AI model to focus on quality, while expanding its Hyperion da...
Growth stocks cooled in early 2026, but a trio of ETFs offers a resilient path for long-term investors. This piece br...
A Global Partners LP COO sold nearly $740k worth of units in a short window. This article explains what insider trade...
Boeing, Honeywell, and 3M all fell in after-hours trading as Q4 results rolled out, signaling divergent paths. This p...
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Centene's Sarah London, the youngest-ever female Fortune 500 CEO, is steering a bold reinvention of the nation's larg...